Back to Prescriptions

When a Medicine Is Withdrawn for Safety

When a Medicine Is Withdrawn for Safety
Prescription Medicines Editorial 4 May 2025

Occasionally a medicine is removed from the market, restricted, or has particular batches recalled because of a safety concern. It is unsettling to hear about, particularly through the news rather than from anyone treating you. The important thing to understand is that there are several quite different situations behind the same headline, and that in almost all of them stopping without arranging a replacement is the bigger risk.

Four different things

Batch recall. Specific batches are affected - a manufacturing fault, contamination, or a packaging error. Other batches of the same product are fine, and the replacement is straightforward.

Product withdrawal or licence suspension. The medicine itself is removed, temporarily or permanently, because the risks are judged to outweigh the benefits.

Restriction. The medicine stays available but its use is narrowed - a new contraindication, a lower maximum dose, a monitoring requirement, or a pregnancy prevention programme. This is much commoner than outright withdrawal.

Commercial discontinuation, which is not a safety matter at all - the manufacturer has stopped making it because it is no longer viable. See why medicines get discontinued.

Which of these applies determines what happens next, so it is worth asking.

What to do

Do not simply stop.

For most medicines the risk from the safety concern is small and spread over years, while the risk from abruptly stopping is immediate. Beta blockers, steroids, anti-epileptics, anticoagulants and Parkinson's medicines all cause harm if stopped suddenly.

Contact your pharmacy first. They will know whether it is a batch issue or a product issue, and whether a replacement is available today.

Then your prescriber, if a different medicine is needed.

Keep taking it until you have that conversation, unless you have been specifically told otherwise.

See why you cannot just stop some medicines.

How the system works

The MHRA monitors safety continuously, using Yellow Card reports, international data and manufacturer information.

When action is needed it issues drug alerts to pharmacies and practices, specifying affected batches and how urgent the response must be - some require action within hours, others at the next routine check.

Ongoing safety advice appears in the monthly Drug Safety Update, which is where restrictions and new warnings are announced.

Pharmacies act on these directly, which is why you may be contacted by your pharmacy rather than your GP.

See how the Yellow Card scheme works and reporting a faulty or fake medicine.

A worked example

The valsartan recalls of 2018 and 2019 illustrate the reasoning well.

Nitrosamine impurities were found in product from certain manufacturers. Affected batches were withdrawn worldwide and manufacturing standards were tightened.

The excess cancer risk from the impurity was estimated to be very small. The risk from someone stopping their blood pressure treatment was not.

So the advice was explicitly not to stop, but to obtain an unaffected supply.

That balance - a small, long-term, theoretical risk against an immediate and concrete one - is typical of these situations.

See valsartan.

Restrictions rather than withdrawal

Most safety action tightens use rather than removing a medicine, and this is where it is most likely to affect you personally.

Recent examples include the pregnancy prevention requirements around valproate and topiramate, the restrictions on JAK inhibitors in people over 65 and smokers, the warnings about montelukast and mood, and the reclassification of gabapentin and pregabalin as controlled drugs.

If a restriction applies to you, it is a reason for a conversation at your next review rather than for stopping unilaterally.

See upadacitinib, topiramate and montelukast.

Reading the news about it

Coverage tends to report relative risk without the underlying frequency, which makes small changes sound alarming.

Useful questions: how many people does this actually affect, over what period, and compared with what alternative?

The MHRA and NHS publish plain statements alongside these stories, and they are a better source than the headline.

Your pharmacist will have read the alert and can tell you whether it applies to you at all.

If you have been taking it

For most withdrawals, no specific action is needed beyond switching - the concern relates to continued exposure rather than to what has already happened.

Where monitoring or investigation is advised, that will be stated explicitly in the alert.

If you had a reaction you think may be related, report it through the Yellow Card scheme - patient reports contribute directly to these decisions.

And return the withdrawn product to a pharmacy rather than leaving it in the cupboard, where it may be taken by mistake later.

See disposing of leftover medicines.

If this was useful, What to Do If Your Medicine Is Out of Stock is worth reading next, and Prescriptions collects the rest.